Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2118 of 6351
-
Can a simple test match the right chemo to each breast cancer patient?
Knowledge-focused OngoingTriple negative breast cancer (TNBC) is a difficult to treat molecular subtype with a poor survival. TNBC can be divided into at least two molecular entities; BRCA-like and non-BRCA-like. In this trial we would like to investigate whether a molecular subgroup exists within TNBCs …
Phase 2 • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Spinal stimulation plus drug may restore arm function in paralysis
Symptom relief OngoingThis study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.
Phase 1/2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy may help liver cancer patients bridge to transplant
Disease control OngoingThis trial is designed to be the initial prospective pilot investigation of the effectiveness of combined SBRT and TACE as bridging therapy for HCC patients awaiting liver transplanation. No prospective clinical trials regarding the combination of TACE and SBRT in pre-transplant …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental drug cocktail targets tough childhood cancers in adults
Disease control CompletedThis research study is a Three arm Phase I clinical trial, which tests the safety of an investigational drug or combination of drugs and also tries to define the appropriate dose of the combination of investigational drugs to use for further studies. "Investigational" means that …
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New cocktail of cancer drugs shows promise in early lymphoma trial
Disease control OngoingThis phase I trial studies the side effects and best dose of lenalidomide and ibrutinib when given together with rituximab in treating patients with previously untreated stage II-IV follicular lymphoma. Lenalidomide may stimulate the immune system in different ways and stop cance…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Your genes may decide if breast cancer drug causes joint pain
Knowledge-focused OngoingE1Z11 is a study to determine whether certain genetic information can predict which breast cancer patients will discontinue treatment with aromatase inhibitors (AIs) due to the development of musculoskeletal symptoms (MSS). Women with stage I-III breast cancer who are prescribed …
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Immune cell boost shows promise against childhood cancers
Disease control CompletedBACKGROUND: * Despite progress, some children and young adults with solid tumors still experience poor survival. * Activated NK cells potently kill autologous pediatric solid tumors, and clinical grade procedures are available to generate large numbers of activated NK cells for …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Zap away kidney tumors without surgery? new trial tests SABR
Disease control OngoingThe goal of this phase II clinical trial is to evaluate the efficacy of the completely non-invasive treatment option of stereotactic radiation therapy for the treatment of biopsy proven and growing small renal tumors.
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New endoscopy method may spot stomach cancer earlier
Diagnosis CompletedThe aim of the present study was to assess whether it was necessary to conduct magnifying endoscopy with narrow band imaging (ME-NBI) targeted biopsy compared with endoscopic forceps biopsy (EFB) from white light endoscopy in diagnosing early gastric cancer (EGC). Meanwhile, the …
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Could a vaccine made from your own cancer cells beat melanoma?
Vaccine CompletedThis research study is a Phase I clinical trial. Phase I clinical trials test the safety of investigational melanoma vaccines. Phase I studies also try to define the appropriate dose of the investigational vaccine, in this case WDVAX, to use for further studies. "Investigational"…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Vaccine
Last updated Jun 26, 2026 17:09 UTC
-
Nasal spray vaccine shows promise against common childhood virus
Vaccine CompletedHuman respiratory syncytial virus (RSV) is a common cause of respiratory illness in infants and children around the world. This study will evaluate the safety and immune response to a RSV vaccine in three groups of participants: healthy children who have already had an RSV infect…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC
-
Blood test could offer gentler way to track Children's heart disease
Knowledge-focused CompletedCardiomyopathy is a disease of the heart muscle. It is rare, but it can be serious. Cardiomyopathy in children can result in death, disability, heart transplantation or serious heart rhythm disorders. Natural substances in the blood called cardiac biomarkers can be measured in th…
Sponsor: Wayne State University • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Could a seizure drug quiet the overactive brain region behind schizophrenia?
Disease control CompletedLevetiracetam (LEV: (S)-α-ethyl-2-oxo-pyrrolidine acetamide) is an anticonvulsant/antiepileptic drug. The specific aim of this study is to assess the efficacy of low-dose LEV in reducing hippocampal activity in schizophrenia. The investigators also hypothesize that LEV will impro…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Frozen ovary transplant could help cancer survivors have babies
Disease control Recruiting nowChemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 26, 2026 16:19 UTC
-
New combo therapy for prostate cancer shows promise in early trial
Disease control CompletedA study to see how effective and tolerable radiation therapy along with androgen deprivation therapy is in treating prostate cancer.
Phase 1/2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can adding a targeted antibody to radiation keep lymphoma away?
Disease control OngoingThis randomized phase I/II trial studies radiation therapy and rituximab in treating patients with stage I-II grade 1 or grade 2 follicular lymphoma. Radiation therapy uses high energy x-rays to kill cancer cells. Immunotherapy with monoclonal antibodies, such as rituximab, may h…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug naderin may help patients fight infections during cancer and TB therapy
Disease control CompletedThis interventional study evaluated the efficacy of Naderin (sodium nucleinate) for the prophylaxis of complications during basic therapy and medical rehabilitation in patients with socially significant diseases, including malignant neoplasms, tuberculosis, and hepatitis C. The s…
Phase 2/3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a daily Under-the-Tongue vaccine tame COPD flare-ups?
Disease control CompletedThe goal of this clinical trial is to learn whether the bacterial vaccine MV130 helps reduce the number of exacerbations in adults with moderate to severe COPD. It will also assess the safety and immune effects of MV130. The main questions it aims to answer is: Does MV130 lower t…
Phase 2/3 • Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can we help parents make better choices for children with cancer?
Knowledge-focused OngoingParental decision-making for children with advanced cancer is complex. Many parents have overly optimistic beliefs about prognosis and as a result choose aggressive measures even at the end of life, which are associated with greater suffering. Yet most parents wish to limit suffe…
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Experimental vaccine aims to stop melanoma recurrence in its tracks
Disease control Recruiting nowThis study is designed for patients who had malignant melanoma and, following tumor removal, are now free of disease, or have only very minor residual disease, and are at a very high risk of disease recurrence. These patients will be treated with the A2/4-1BBL melanoma vaccine, a…
Phase 1/2 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC